Abstract:INTRODUCTION:LDH-A, the enzyme responsible for transforming pyruvate into lactate, has been demonstrated to be up-regulated in many types of cancer and to give rise to more aggressive behavior by regulating proliferation and anti-apoptosis. However, its expression in gastric cancer (GC) has not been characterized thoroughly. The purpose of this study was to clarify the expression and potential impact of LDH-A in GC.METHODS:We examined LDH-A expression by immunohistochemistry on GC tissue microarray (TMA) and using Western blot on fresh GC tissues and cell lines. Prognostic value and correlation with other clinicopathologic factors were evaluated. We transfected siRNA into GC cells against LDH-A. LDH-A was analyzed by Western blotting and real-time RT-PCR. Cell growth was evaluated in vitro and in vivo. Lactate and ATP production by cells were determined.RESULTS:There was significantly higher LDH-A expression in carcinoma than in non-neoplastic mucosa (NNM). There was a positive correlation of LDH-A expression with age, histological type and Lymph node metastases. Survival analysis demonstrated that high expression of LDH-A in GC was associated with lower overall survival (OS). When stratified by Lauren grade and histological classification, significance appeared in diffuse type and undifferentiated type GC. In multivariate analysis, the LDH-A expression in GC was an independent prognostic risk factor for OS (hazard ratio = 1.829, 95%CI 1.375-2.433,P<0.0001). Specific siRNA against LDH-A in GC cell line retarded cell growth both in vitro and in mouse models. LDH-A knockdown also reduced lactate and ATP production in GC cells.CONCLUSIONS:Our study indicated the oncogenic role of LDH-A in GC. LDH-A expression is an independent prognostic risk factor in GC patients and up-regulated expression of LDH-A could be predictive of poor outcomes in diffuse type and undifferentiated type GC. Our results suggested that LDH-A might be a potential therapeutic target in gastric cancer.

Aldehyde Dehydrogenase 1 in Gastric Cancer

Aldehyde Dehydrogenase 3A1 is Robustly Upregulated in Gastric Cancer Stem-Like Cells and Associated with Tumorigenesis.

Aldehyde Dehydrogenases and Cancer Stem Cells.

Identification of ALDH3A2 As a Novel Prognostic Biomarker in Gastric Adenocarcinoma Using Integrated Bioinformatics Analysis

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.

Weighted Gene Co-expression Network Analysis Reveals ALDH1B1 As a Prognositc Biomarker Involved in Gastric Cancer Development

Clinicopathological Significance of ALDH1A1 in Lung, Colorectal, and Breast Cancers: a Meta-Analysis.

Potential clinical significance of ALDH3B1 in auxiliary diagnosis of gastric cancer

Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment

Aldehyde dehydrogenase 1 is a tumor stem cell-Associated marker in lung cancer

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma

Cancer Stem Cell Marker ALDH1 Expression is Associated with Lymph Node Metastasis and Poor Survival in Esophageal Squamous Cell Carcinoma: a Study from High Incidence Area of Northern China.

Exploring the Role and Pathophysiological Significance of Aldehyde Dehydrogenase 1B1 (ALDH1B1) in Human Lung Adenocarcinoma

Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis

The role of ALDH1A1 in glioblastoma proliferation and invasion

The Molecular Mechanism and Clinical Significance of LDHA in HER2-mediated Progression of Gastric Cancer.

Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets

Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients.

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors

Functional Clustering Analysis Identifies Specific Subtypes of Aldehyde Dehydrogenase Associated with Glioma Immunity